M&A alert. MedLife takes over Anima

Newsroom 06/02/2017 | 15:20

Romanian private healthcare oprator MedLife has taken over Anima, an ambulatory medical services supplier for services reimbursed by the Health Insurances Agency of Bucharest Municipality (CASMB), according to a press release of the Bucharest Stock Exchange (BVB).

„Anima Specialty Medical Services has six polyclinics and a laboratory, over 200 employees, doctors and support personnel, being the first private medical network with personal  general practitioner network from Romania. At the same time, Anima is one of the private suppliers of ambulatory medical services that has contract with CASMB, covering 15 specialties,” says the release.

According to the representatives of the company, Anima has currently 75,000 corporate subscribers focused especially on the services from labor medicine. In 2016, Anima registered a turnover of EUR 5.2 million.

„Anima will be an autonomous company, with a sales department that will function differently and independently of what MedLife brand promotes. We’ll keep the current management that we trust. As we do in all the acquisitions, after the takeover we’ll identify the functions and activities that we could make efficient to get the scale economy,” said Mihai Marcu, president and CEO MedLife.

According to him, the finalization of the acquisition is conditioned by the approval of the Competition Council.

The integral acquisition of clinics network Anima represents the fifteenth acquisition of MedLife.

MedLife shares were flat at RON 25.8000 on Monday trading on the Bucharest Stock Exchange.

BR Magazine | Latest Issue

Download PDF: Business Review Magazine April 2024 Issue

The April 2024 issue of Business Review Magazine is now available in digital format, featuring the main cover story titled “Caring for People and for the Planet”. To download the magazine in
Newsroom | 12/04/2024 | 17:28
Advertisement Advertisement
Close ×

We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

Accept & continue